Analysis of a large prostate cancer family identifies novel and recurrent gene fusion events providing evidence for inherited predisposition-Reference-Cited by-同舟云学术

Analysis of a large prostate cancer family identifies novel and recurrent gene fusion events providing evidence for inherited predisposition

Published:2022-01-07 Issue:5 Volume:82 Page:540-550
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Raspin Kelsie¹,O'Malley Dannielle E.¹,Marthick James R.¹,Donovan Shaun²,Malley Roslyn C.²³,Banks Annette¹,Redwig Frank⁴,Skala Marketa⁵,Dickinson Joanne L¹,FitzGerald Liesel M.¹^ORCID

Affiliation:

1. Menzies Institute for Medical Research University of Tasmania Hobart TAS Australia

2. Hobart Pathology Hobart TAS Australia

3. School of Medicine University of Tasmania Hobart TAS Australia

4. Department of Urology Royal Hobart Hospital Hobart TAS Australia

5. WP Holman Clinic Royal Hobart Hospital Hobart TAS Australia

Funder

Royal Hobart Hospital Research Foundation

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24300

Reference54 articles.

1. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

2. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

3. Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer

4. Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review

5. Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DeeP4med: deep learning for P4 medicine to predict normal and cancer transcriptome in multiple human tissues;BMC Bioinformatics;2023-07-04

2. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma;BMC Cancer;2023-03-23

3. Identification of a novel recurrent EEF2 gene amplification in familial prostate tumors;Genes, Chromosomes and Cancer;2022-12-23